I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Joerger, M.
~ 300
results:
Search for persons
X
Format
Online
Mediatypes
E-Books
Articles (Online)
OpenAccess-fulltext
Languages
english (236)
german (1)
more...
french (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
SAKK57/16 Nab-paclitaxel and Gemcitabine in Soft Tissue Sar..:
Digklia, A.
;
Kollár, A.
;
Dietrich, D.
...
European Journal of Cancer. 197 (2024) - p. 113470 , 2024
Link:
https://doi.org/10.1016/..
?
2
146P A novel allosteric oral immunotherapy small molecule m..:
Pejoski, D.
;
Suess, C.
;
Gouiller, A.
...
Immuno-Oncology and Technology. 20 (2023) - p. 100618 , 2023
Link:
https://doi.org/10.1016/..
?
3
118O Definitive results for NSCLC and bladder cancer cohort..:
Melero, I.
;
De Miguel, M.J.
;
Casal, G. Alonso
...
Immuno-Oncology and Technology. 20 (2023) - p. 100590 , 2023
Link:
https://doi.org/10.1016/..
?
4
Implementation of dihydropyrimidine dehydrogenase deficienc..:
de With, M.
;
Sadlon, A.
;
Cecchin, E.
...
ESMO Open. 8 (2023) 2 - p. 101197 , 2023
Link:
https://doi.org/10.1016/..
?
5
How to read a next-generation sequencing report—what oncolo..:
Schmid, S.
;
Jochum, W.
;
Padberg, B.
...
ESMO Open. 7 (2022) 5 - p. 100570 , 2022
Link:
https://doi.org/10.1016/..
?
6
194P Thermal ablation followed by intratumoral injection of..:
Joerger, M.
;
Knüsel, P.
;
Alejandre-Lafont, E.
...
Immuno-Oncology and Technology. 16 (2022) - p. 100306 , 2022
Link:
https://doi.org/10.1016/..
?
7
200MO Anti–IL-8 BMS-986253 + nivolumab (NIVO) ± ipilimumab ..:
Simonelli, M.
;
Calvo, E.
;
Davar, D.
...
Immuno-Oncology and Technology. 16 (2022) - p. 100311 , 2022
Link:
https://doi.org/10.1016/..
?
8
19P Effects of CTLA-4 single nucleotide polymorphisms (SNPs..:
Joode, K.D.
;
Rojas Mora, A.
;
Van Schaik, R.
...
Immuno-Oncology and Technology. 16 (2022) - p. 100124 , 2022
Link:
https://doi.org/10.1016/..
?
9
LC3A positive "stone like structures" are differentially as..:
Gachechiladze, M.
;
Uberall, I.
;
Skanderova, D.
...
Lung Cancer. 156 (2021) - p. 129-135 , 2021
Link:
https://doi.org/10.1016/..
?
10
Continuous vs intermittent adenosine 2A receptor (A2AR) inh..:
Lin, C.C.
;
Joerger, M.
;
Grell, P.
...
European Journal of Cancer. 138 (2020) - p. S12-S13 , 2020
Link:
https://doi.org/10.1016/..
?
11
OFF‐LABEL USE IN LYMPHOMA PATIENTS IN SWITZERLAND:
Herbrand, A.K.
;
Schmitt, A.M.
;
Joerger, M.
..
Hematological Oncology. 37 (2019) S2 - p. 537-538 , 2019
Link:
https://doi.org/10.1002/..
?
12
Phase I trial of the oral smoothened inhibitor sonidegib in..:
Stathis, A.
;
Hess, D.
;
von Moos, R.
...
Investigational New Drugs. 35 (2017) 6 - p. 766-772 , 2017
Link:
https://doi.org/10.1007/..
?
13
Novel Genetic Variants in Carboxylesterase 1 Predict Severe..:
Hamzic, S
;
Kummer, D
;
Milesi, S
...
Clinical Pharmacology & Therapeutics. 102 (2017) 5 - p. 796-804 , 2017
Link:
https://doi.org/10.1002/..
?
14
Pharmacogenetic variants associated with outcome in patient..:
Meulendijks, D
;
Rozeman, E A
;
Cats, A
...
The Pharmacogenomics Journal. 17 (2016) 5 - p. 441-451 , 2016
Link:
https://doi.org/10.1038/..
?
15
The impact of ABCC11 polymorphisms on the risk of early-ons..:
Hamzic, S
;
Wenger, N
;
Froehlich, T K
...
The Pharmacogenomics Journal. 17 (2016) 4 - p. 319-324 , 2016
Link:
https://doi.org/10.1038/..
1-15